Print Page | Close Window

2015 News Releases

Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009
DateTitle 
03/04/15GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results
Company to initiate two open-label Phase 2 clinical trials of enobosarm for two breast cancer indications Conference call today at 9:00 a.m. ET MEMPHIS, Tenn.--(BUSINESS WIRE)--Mar. 4, 2015-- GTx, Inc. (Nasdaq: GTXI) today reported financial results for the fourth quarter and year ended December 31, 2014, and highlighted recent accomplishments and upcoming milestones. The Company remains focused on targeting the androgen receptor in ... 
Printer Friendly Version
02/19/15GTx, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast
MEMPHIS, Tenn.--(BUSINESS WIRE)--Feb. 19, 2015-- GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company’s fourth quarter and full year 2014 financial results on Wednesday, March 4, at 9:00 a.m. Eastern Time. The call and webcast will follow the release of the financial results earlier that day. To listen to the conference call, please dial: ... 
Printer Friendly Version
02/17/15GTx Appoints Robert J. Wills, Ph.D. to Board of Directors
– Industry Veteran to serve as Executive Chairman of the Board and Chair of the Board’s Scientific and Development Committee – MEMPHIS, Tenn.--(BUSINESS WIRE)--Feb. 17, 2015-- GTx, Inc. (NASDAQ: GTXI) today announced that Robert J. Wills, Ph.D., has been appointed to the Company's Board of Directors and will serve as GTx’s Executive Chairman as well as the Chairman of the Board’s Scientific and Development Committee, in each case effective March 2, ... 
Printer Friendly Version